This study investigates advanced, metastatic solid tumors. The purpose of this study is to understand how an investigational medication affects these conditions.
The study evaluates the safety and effectiveness of the investigational medication. It looks at how the body processes the medication and its overall impact on the tumors.
- Who can participate: Adults aged 18 and older with advanced or metastatic solid tumors may join. Participants should have tried standard treatments or have no other options.
- Study details: Participants will receive an investigational treatment. Some may receive a placebo. Participants need to be willing to provide tumor samples for research.